Group 1 - The report highlights the selection of 12 innovative companies from the North Exchange, focusing on their strong technological attributes and scarcity in the market, with an average revenue of 582 million yuan and an average net profit of 72.05 million yuan for 2024 [2][4][10] - Key selected companies include: - Caike Technology: A specialized fine chemical "little giant" with expected revenue of 454 million yuan and net profit of 115.64 million yuan in 2024 [2][3] - Meikang Co., Ltd.: A leader in medical knowledge base construction, with expected revenue of 245 million yuan and net profit of 91.09 million yuan in 2024 [2][3] - Aikem: A "little giant" in pre-dispersed rubber additives, with expected revenue of 516 million yuan and net profit of 84.22 million yuan in 2024 [2][3] - Fuyin New Materials: A "little giant" in precision functional materials, with expected revenue of 724 million yuan and net profit of 81.83 million yuan in 2024 [3][4] - Tianjian New Materials: A leading company in high-performance modified plastics, with expected revenue of 1.129 billion yuan and net profit of 63.52 million yuan in 2024 [3][4] - Juxin Technology: A "little giant" in semiconductor power devices, with expected revenue of 564 million yuan and net profit of 54.53 million yuan in 2024 [3][4] - Tiniou Technology: Focused on semiconductor cleaning equipment, with expected revenue of 148 million yuan and net profit of 49.08 million yuan in 2024 [3][4] Group 2 - The North Exchange has a rich reserve of new productivity companies, including 189 companies accepted for listing, covering high-end equipment manufacturing, TMT, chemical new materials, consumption, and biomedicine [1][10][13] - Among the companies awaiting approval, 153 are in various stages, with the highest number in high-end equipment (54 companies) and TMT (28 companies), showing an average revenue of 830 million yuan and net profit of 95.79 million yuan for 2024 in the high-end equipment sector [1][13][14] - The report emphasizes the importance of innovation and technology in driving industrial growth and enhancing productivity, aligning with government initiatives to promote a modern industrial system [10][12]

瑞财经 刘治颖 近日，四川美康医药软件研究开发股份有限公司（以下简称：美康股份）披露北交所IPO辅导工作完成报告，辅导机构东兴证券。 2024年12月26日，东兴证券与美康股份签署了《辅导协议》，美康股份于2024年12月31日正式进入辅导期。截至本报告签署日，东兴证券共开展了一期辅导 工作。 股权方面，赖琪直接持有公司1.02%的股权，通过新鑫美康间接控制公司48.84%的股份，合计控制公司49.86%的股份，并担任公司董事长、总经理，其控制 的股份足以对公司股东大会的决议产生重大影响，为公司的实际控制人。 瑞财社注意到，美康股份80后女高管张芷菱身兼三职，既是财务总监、董事会秘书，又是副总经理。 公开资料显示，张芷菱，1980年10月出生，中国国籍，无境外居留权，毕业于东北财经大学，ACCA。2007年1月至2008年10月，任Harrods Ltd.财务部财务 助理；2008年10月至2011年12月，历任LCCO&CO注册会计师事务所会计、审计经理；2012年3月至2012年12月，任四川省文君酒经营有限责任公司财务部 财务内控主任；2013年1月至2014年11月，任北京威科亚太信息技术有限公司财务 ...